4//SEC Filing
GLOBEIMMUNE INC 4
Accession 0001209191-16-098769
CIK 0001245104operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:40 PM ET
Size
19.3 KB
Accession
0001209191-16-098769
Insider Transaction Report
Form 4
GLOBEIMMUNE INCGBIM
HEALTHCARE VENTURES VII LP
10% Owner
Transactions
- Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership)
HealthCare Partners VII, L.P.
10% Owner
Transactions
- Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership)
LITTLECHILD JOHN W
10% Owner
Transactions
- Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership)
Mirabelli Christopher
10% Owner
Transactions
- Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership)
WERNER HAROLD R
10% Owner
Transactions
- Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership)
CAVANAUGH JAMES H
10% Owner
Transactions
- Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership)
LAWLOR AUGUSTINE
Director10% Owner
Transactions
- Sale
Common Stock
2016-02-12$1.59/sh−5,000$7,950→ 574,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-11$1.72/sh−5,000$8,600→ 579,267 total(indirect: By Partnership) - Sale
Common Stock
2016-02-16$1.51/sh−5,000$7,550→ 569,267 total(indirect: By Partnership)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 - $1.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]These securities are held of record by HealthCare Ventures VII, L.P. ("HCVVII"). HealthCare Partners VII, L.P. ("HCPVII") is the General Partner of HCVVII. Each of James Cavanaugh, Christopher Mirabelli, Harold Werner, John Littlechild and Augustine Lawlor are general partners of HCPVII and exercise shared voting and investment power with respect to the shares owned by HCVVII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of their proportionate pecuniary interest therein. In addition, Mr. Lawlor is a member of the Board of Directors of the Issuer.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.47 - $1.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.47 - $1.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (4) to this Form 4.
Documents
Issuer
GLOBEIMMUNE INC
CIK 0001245104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001245104
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:40 PM ET
- Size
- 19.3 KB